Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Haematology > Multiple Myeloma and MGUS (+some lymphoma) > Flashcards

Multiple Myeloma and MGUS (+some lymphoma) Flashcards

1
Q

What are lymphomas?

A

Collection of lymphoid malignancies in which malignant lymphocytes accumulate at LNs and lymphoid tissues; leads to lymphadenopathy, extra nodal disease and constitutional symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is Hodgkin distinguished from non-Hodgkin lymphoma?

A

Presence of Reed Sternberg cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How are lymphomas staged?

A

Ann Arbor System (Stage I-IV). Based on LN / extra nodal involvement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the effect and associated neoplasm of t(8;14)?

A

c-myc activation; Burkitt’s lymphoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the effect and associated neoplasm of t(14;18)?

A

bcl-2 activation; Follicular lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the effect and associated neoplasm of t(9;22)?

A

Philadelphia chr (bcr-abl); CML/ALL in adults (25%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the effect and associated neoplasm of t(11;14)?

A

Overexertion of cyclin D1 protein.

Mantle cell lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is multiple myeloma?

A

Neoplastic clonal proliferation of plasma cells producing a monoclonal immunoglobulin resulting in end organ dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Epidemiology of multiple myeloma?

A

3/100 000. Most common plasma cell malignancy.

-Increased frequency with age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Features of end organ damage in multiple myeloma?

A

CRAB

  • Increased Calcium
  • Renal failure
  • Anemia
  • Bony lesions (lytic lesions or osteoporosis felt to be caused by myeloma)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pathophysiology of multiple myeloma?

A

Malignant plasma cells secrete monoclonal antibody (95% produce M protein = monoclonal Ig)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pathogenesis of multiple myeloma?

A
  • Transition of normal plasma cells to precursor disease (monoclonal gammopathy of uncertain significance;MGUS)
  • Reflects progression of oncogenic events with acquisition of mutations and cytogenetic abnormalities en route ==> karyotypic instability.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Marrow appearance in multiple myeloma?

A

Normal marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does the marrow microenvironment facilitate multiple myeloma?

A

Bone marrow microenvironment promotes proliferation and blocks apoptosis of plasma cells.

  1. MM cells adhere to ECM proteins of bone marrow through adhesion molecules e.g. VLA4, VCAM1, ICAM1
  2. Bone marrow homing further facilitated by MM expression of other adhesion molecules e.g. CD138, CD38, CD106
  3. MM binding induces transcription and secretion of cytokines (e.g. TNFa, IL6, IGF, VEGF), triggering signalling pathways promoting proliferation and preventing apoptosis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What do normal plasma cells secrete?

A

Immunoglobulins, composed of heavy chains and light chains. These are polyclonal i.e. different for each plasma cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What Ig do MM cells secrete?

A

CLONAL Ig: intact paraprotein = M protein (or just the light chain component of light chain only MM).

17
Q

How can light chains be detected in the serum or urine?

A

Bence Jones protein

18
Q

What are the features of monoclonal gammopathy of uncertain significance?

A

-serum M protein

19
Q

What is asymptomatic (smouldering) myeloma?

A 
-M protein in serum at myeloma levels (>30g/L)
AND/OR
-10% or more clonal plasma cells in BMA
BUT
NO CRAB
20
Q

What are the diagnostic criteria for Multiple Myeloma?

A
  • M PROTEIN in serum or urine: >30g/L of IgG or >25g/L IgA or light chain in urine/serum
  • Marrow clonal plasma cells: >10% nucleated cells in marrow
  • CRAB (end organ damage)
21
Q

When should myeloma be suspected?

A
  • # or bone pain w/o precipitating event
  • XR shows lytic lesions, severe osteoporosis or crush #
  • Unexplained anaemia w/ rouleaux on film and high ESR
  • High total protein despite N albumin level
  • Unexplained hypercalcemia
  • Unexplained renal failure
22
Q

Ix in ?MM?

A
  • FBE (Anaemia)
  • UEC (renal function)
  • Calcium (hypercalcemia)
  • Serum and urine protein electrophoresis and measurement of free light chains
  • B2 microglobulin, serum alb, LDH (prognostic markers)
  • BMA
  • Imaging: skeletal survey, ?spinal MRI
23
Q

Bone marrow examination in MM?

A
  • Morphology of aspirate and trephine
  • Quantify plasma cells CD138 stain
  • Cytogenetics and FISH for chromosomal abnormalities (prognostic info)
24
Q

Imaging in MM?

A
  • Skeletal survey

- Spinal MRI: severe back pain, ?cord compression, multiple lesions (++sens)

25
Q

Describe bone lesions in myeloma.

A

Vast majority purely lytic, sharply defined / punched out with endosteal scalloping when abutting cortex.
-Sclerotic in 3% only
-Osteopenia
-Crush #s of vertebrae
Due to tumour growth and activation of osteoclasts (IL6)

26
Q

Medical management of hypercalcemia in MM?

A

Rehydration and IV bisphosphonate

27
Q

Treatment of underlying disease in MM?

A
  • Chemotherapy
  • Judicious transfusions if severely anaemic
  • Bisphosphonates for bone disease
28
Q

Medical emergencies in MM?

A
  • Hypercalcemia
  • Spinal cord compression
  • Renal failure
  • Hypervisocsity (uncommon)
  • Infections
29
Q

Chemotherapy in myeloma treatment?

A
  • Thalidomide based induction in combination with alkylator and steroids (e.g. cyclo/thal/dexa= CTD)
  • lenalidomide or bortezomib for relapse
  • autologous transplants
30
Q

Treatment of MGUS?

A

No treatment! Annual monitoring due to 1-2% risk of progression to myeloma.

31
Q

DO most patients with MGUS have myeloma?

A

NO! Look for CRAB features.

32
Q

Why are skeletal surveys used over bone scans in MM work up?

A

Variable osteoblastic activity may lead to neg MM bone scan.

33
Q

Patterns of MM?

A
  1. Disseminated: multiple lytic lesions (predom axial)
  2. Disseminated: diffuse skeletal osteopenia
  3. Solitary plasmacytoma
  4. Osteosclerosing myeloma
34
Q

Components of skeletal survey?

A
  1. Lateral skull
  2. Frontal chest film
  3. Cervico-thoraco-lumbar spine
  4. Shoulders
  5. Pelvis
  6. Femurs
35
Q

Main Ddx of MM on imaging?

A

Widespread bony mets

36
Q

Features distinguishing bony mets and MM?

A

Bony mets over MM

  • vertebral pedicles affected > bodies
  • rarely involve mandible, distal axial skeleton
  • bony mets rarely have normal bone scan appearance

Haematology (25 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions